AMPLIFON S.P.A. EO-,02/ IT0004056880 /
02.05.2024 08:10:02 | Diff. 0.000 | Volumen | Geld13:43:37 | Brief13:43:37 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
31.670EUR | 0.00% | 0 Umsatz: 0.000 |
31.560Geld Vol: 500 | 31.640Brief Vol: 500 | 7.14 Mrd.EUR | 0.92% | 45.62 |
GlobeNewswire
13:59
CompTIA introduces new Data Advisory Council to help businesses foster data-driven culture
GlobeNewswire
13:59
60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; ...
Newsfile Corp
13:36
PlasCred Circular Innovations Inc. kündigt strategische Vereinbarung über Wachstumskapital mit Nimbu...
GlobeNewswire
13:31
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM...
GlobeNewswire
13:30
Guangzhou Bio-gene Technologies Announces Initiation of Phase I Clinical Trial for BG1805, a CAR-T T...
GlobeNewswire
13:30
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire
13:30
GURU Organic Energy Enters Zero Sugar Segment With Metabolism-Boosting GURU Zero Wild Berry
GlobeNewswire
13:30
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13:30
Clubhouse Media Group, Inc. Announces HoneyDrip.com Growth Results For April 2024
GlobeNewswire
13:30
FuelCell Energy and Toyota Motor North America Celebrate Launch of World's First "Tri-gen" Productio...
GlobeNewswire
13:30
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Upd...
GlobeNewswire
13:30
The 2024 Xos SV Stepvan Now Available for Incentives on the HVIP Vehicle Catalog
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite